Literature DB >> 29449133

Evaluation of Medicare's Intensive Behavioral Therapy for Obesity: the BieneStar Experience.

Roberto P Treviño1, Christina Piña2, Jesús Cuéllar Fuentes3, Melissa Nuñez4.   

Abstract

INTRODUCTION: In 2011, the Centers for Medicare and Medicaid Services began to reimburse primary care providers for intensive behavior therapy for obesity. This study evaluated a Centers for Medicare and Medicaid Services intensive behavior therapy for obesity program as implemented in primary care clinics.
METHODS: Data for this retrospective cohort study were obtained between May 2012 and February 2015 and statistical analysis was performed in 2017. The sample included 643 participants who attended at least one BieneStar intensive behavior therapy for obesity program session. The primary outcome was weight, and covariates were number of sessions, age, race/ethnicity, diagnosis of hypertension and diabetes, and type of health insurance.
RESULTS: Of 643 participants that initiated the BieneStar program, 641 had complete data. The median reduction in weight of participants was as follows: those who attended fewer than four sessions, 0 kg (95% CI=0, 0.11 kg); between four and eight sessions, 1.1 kg (95% CI=0.86, 1.59 kg); and more than eight sessions 3.7 kg (95% CI=3.36, 4.55 kg). Medians of weight were significantly different between each classification of session numbers (p<0.01). Participants lost on average 0.102 kg of weight per session attended.
CONCLUSIONS: The BieneStar program showed that the weight of participants decreased as they attended more sessions. Further studies are needed to determine if these results can be reproduced in other office-based primary care clinics and the program's impact on chronic disease.
Copyright © 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29449133     DOI: 10.1016/j.amepre.2018.01.018

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  5 in total

1.  Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial.

Authors:  Thomas A Wadden; Olivia A Walsh; Robert I Berkowitz; Ariana M Chao; Naji Alamuddin; Kathryn Gruber; Sharon Leonard; Kimberly Mugler; Zayna Bakizada; Jena Shaw Tronieri
Journal:  Obesity (Silver Spring)       Date:  2018-11-13       Impact factor: 5.002

2.  Exposure to Weight Management Counseling Among Students at 8 U.S. Medical Schools.

Authors:  Karen M Ashe; Alan C Geller; Jyothi A Pendharkar; Lori Pbert; Sybil Crawford; Melissa A Clark; Christine F Frisard; Cassie A Eno; Jamie Faro; Judith K Ockene
Journal:  Am J Prev Med       Date:  2021-02-22       Impact factor: 5.043

3.  A Survey of Primary Care Practices on Their Use of the Intensive Behavioral Therapy for Obese Medicare Patients.

Authors:  Zhehui Luo; Mark Gritz; Lauri Connelly; Rowena J Dolor; Phoutdavone Phimphasone-Brady; Hanyue Li; Laurie Fitzpatrick; McKinzie Gales; Nikita Shah; Jodi Summers Holtrop
Journal:  J Gen Intern Med       Date:  2021-01-22       Impact factor: 6.473

4.  Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico.

Authors:  Rolando Giovanni Díaz-Zavala; Maria Del Carmen Candia-Plata; Teresita de Jesús Martínez-Contreras; Julián Esparza-Romero
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-13       Impact factor: 3.168

5.  The association of obesity with health insurance coverage and demographic characteristics: a statewide cross-sectional study.

Authors:  Evangelia K Mylona; Gregorio Benitez; Fadi Shehadeh; Elvira Fleury; Sophia C Mylonakis; Markos Kalligeros; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.